Back
Caesars Entertainment Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
70
CZR
Caesars Entertainment
Last Price:
39.03
Seasonality Move:
8.33%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Buy
70
Caesars Entertainment (CZR)
is a Buy
Is Caesars Entertainment a Buy, Sell or Hold?
- The current Caesars Entertainment [CZR] share price is $38.17. The Score for CZR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- CZR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CZR Stock Price Chart
What is Caesars Entertainment's stock price today?
-
The Caesars Entertainment share price today is $38.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CZR is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CZR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 55.98 | Buy |
| Chaikin Money Flow: | 610480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34 - 38.12) | Buy |
| Bollinger Bands (100): | (36.09 - 42.55) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.17 | Buy |
| Relative Strength Index (14 RSI): | 68.43 | Buy |
| Chaikin Money Flow: | 1613298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.82 - 142.64) | Buy |
| Bollinger Bands (100): | (118.8 - 136.1) | Buy |
CZR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.82 | Buy |
| 20-day SMA: | 36.59 | Buy |
| 50-day SMA: | 36.47 | Buy |
| 200-day SMA: | 42.33 | Sell |
| 8-day EMA: | 37.96 | Buy |
| 20-day EMA: | 37.13 | Buy |
| 50-day EMA: | 37.36 | Buy |
| 200-day EMA: | 41.77 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.03 | Buy |
| 20-day SMA: | 129.22 | Buy |
| 50-day SMA: | 127.95 | Buy |
| 200-day SMA: | 115.45 | Buy |
| 8-day EMA: | 145.32 | Buy |
| 20-day EMA: | 134.79 | Buy |
| 50-day EMA: | 129.39 | Buy |
| 200-day EMA: | 120.67 | Buy |
Caesars Entertainment Earnings Growth & CZR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, a decrease this year of $3.06 per share, and an increase next year of $0.83 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Caesars Entertainment Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||